Cargando…
Autoantibodies against the Catalytic Domain of BRAF Are Not Specific Serum Markers for Rheumatoid Arthritis
BACKGROUND: Autoantibodies to the catalytic domain of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) have been recently identified as a new family of autoantibodies involved in rheumatoid arthritis (RA). The objective of this study was to determine antibody responses to the catalytic domain...
Autores principales: | Li, Wenli, Wang, Wei, Sun, Shipeng, Sun, Yu, Pan, Yang, Wang, Lunan, Zhang, Rui, Zhang, Kuo, Li, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236235/ https://www.ncbi.nlm.nih.gov/pubmed/22174938 http://dx.doi.org/10.1371/journal.pone.0028975 |
Ejemplares similares
-
Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis
por: Charpin, Caroline, et al.
Publicado: (2010) -
Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection
por: Sun, Shipeng, et al.
Publicado: (2011) -
Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease
por: Sánchez-Tirado, Esther, et al.
Publicado: (2023) -
Increased Kappa/Lambda Hybrid Antibody in Serum Is a Novel Biomarker Related to Disease Activity and Inflammation in Rheumatoid Arthritis
por: Yi, Lang, et al.
Publicado: (2016) -
Autoantibodies against citrullinated serum albumin in patients with rheumatoid arthritis
por: Hefton, Amanda, et al.
Publicado: (2019)